Published in 2020, the Dapagliflozin in Chronic Kidney Disease (DAPA-CKD) randomized 4,304 patients with CKD (defined by eGFR of 25 to 75 and albuminuria with ACR of 200 to 5000 mg/g) with and without T2DM to dapagliflozin or placebo. The study was halted early after an interim safety analysis found evidence of benefit as dapagliflozin was found to reduce the composite endpoint of decline of ≥50% in eGFR, new ESRD, renal mortality, or CVD mortality (9.2% vs. 14.5%; HR 0.61; 95% CI 0.51-0.72; NNT=19). Importantly, this benefit was similar regardless of T2DM status. The medication was also associated with reduction in other endpoints, including all-cause mortality (4.7% vs. 6.8%; 0.69; 0.53-0.88; NNT=48). There was a slightly higher risk of major hypoglycemia (0.7% vs. 1.3%; P=0.04; NNH=166) with dapagliflozin use.

Published in 2020, the Dapagliflozin in Chronic Kidney Disease (DAPA-CKD) randomized 4,304 patients with CKD (defined by eGFR of 25 to 75 and albuminuria with ACR of 200 to 5000 mg/g) with and without T2DM to dapagliflozin or placebo. The study was halted early after an interim safety analysis found evidence of benefit as dapagliflozin was found to reduce the composite endpoint of decline of ≥50% in eGFR, new ESRD, renal mortality, or CVD mortality (9.2% vs. 14.5%; HR 0.61; 95% CI 0.51-0.72; NNT=19). Importantly, this benefit was similar regardless of T2DM status. The medication was also associated with reduction in other endpoints, including all-cause mortality (4.7% vs. 6.8%; 0.69; 0.53-0.88; NNT=48). There was a slightly higher risk of major hypoglycemia (0.7% vs. 1.3%; P=0.04; NNH=166) with dapagliflozin use.

MATLAB: An Introduction with Applications

6th Edition

ISBN:9781119256830

Author:Amos Gilat

Publisher:Amos Gilat

Chapter1: Starting With Matlab

Section: Chapter Questions

Problem 1P

See similar textbooks

Similar questions

A randomized controlled trial was conducted to determine whether treatment with daily aspirin was more effective than placebo at preventing myocardial infarction (MI) (within 5 years). A total of 140 out of 11,140 subjects in the aspirin group experienced an MI, while 240 out of 11,040 subjects in the placebo group experienced an MI. The relative risk of MI comparing aspirin to placebo was calculated to be 0.58, and its 95% confidence interval ranged from 0.47 to 0.71. Which of the following can be concluded from these results? Question 4 options: On average, the risk of MI among subjects who used aspirin was 0.58 times the risk of MI among those on placebo. On average, aspirin reduced the risk of MI in this population by 58% when compared to placebo. Aspirin is almost certainly harmful to this population. Compared to placebo, aspirin did not reduce the risk of MI by a statistically significant amount.
Captopril is a drug designed to lower systolic blood pressure. When subjects were treated with this drug, their systolic blood pressure readings (in mm Hg) were measured before and after the drug was taken. Results are given in the accompanying table (based on data from “Essential Hypertension: Effect of an Oral Inhibitor of Angiotensin-Converting Enzyme”, by MacGregor et al., BMJ, Vol. 2). Using a 0.01 significance level, is there sufficient evidence to support the claim that captopril has an effect on systolic blood pressure? i) Use the Wilcoxon signed-ranks test to conduct the required test without using "wilcox.test" function in R. Please state the hypothesis, provide the p-value, and the conclusion in the context of the problem. ii) Use the Wilcoxon signed-ranks test to conduct the required test using "wilcox.test" function in R. Please present a screenshot of the R output of your call to the function wilcox.test. iii) Would you recommend the Wilcoxon signed-ranks test over the…
A study was conducted that measured the total brain volume (TBV) (in ) of patients that had schizophrenia and patients that are considered normal. Table #9.3.5 contains the TBV of the normal patients and table #9.3.6 contains the TBV of schizophrenia patients ("SOCR data oct2009," 2013). Is there enough evidence to show that the patients with schizophrenia have less TBV on average than a patient that is considered normal? Test at the 10% level. (Show work) Table #9.3.5: Total Brain Volume (in ) of Normal Patients 1663407 1583940 1299470 1535137 1431890 1578698 1453510 1650348 1288971 1366346 1326402 1503005 1474790 1317156 1441045 1463498 1650207 1523045 1441636 1432033 1420416 1480171 1360810 1410213 1574808 1502702 1203344 1319737 1688990 1292641 1512571 1635918 Table #9.3.6: Total Brain Volume (in ) of Schizophrenia Patients 1331777 1487886 1066075 1297327 1499983…
Anemia (low healthy blood cells or hemoglobin) has an important role in exercise performance. However, the direct link between rapid changes of hemoglobin and exercise performance is still unknown. A study investigated 18 patients with a blood disorder (beta-thalassemia). Participants in the study performed an exercise test before and the day after receiving a blood transfusion. Data are given in the table. HB = Hemoglobin RER = Respiratory exchange ID Change in HB Obese RER > 1.1 ratio No No 1 -1.4 No -1.5 No Yes No Yes 3 -2 No 4 -2.1 No -1.9 Yes Yes No -1.6 -1.8 -0.8 6 7 No Yes No Yes 8 9. -1 No No -1.2 No Yes 10 11 No No -0.8 -1.5 12 Yes No No Yes 13 14 -1.4 -2.6 -1.7 No No Yes Yes 15 Yes No Yes Yes 16 -2.6 No 17 18 -2.7 -1.5 No
Serum estradiol is an important risk factor for breast cancer in postmenopausal women. To better understand the etiology of breast cancer, serum-estradiol samples were collected from 25 premenopausal women (at about the same time period of the menstrual cycle) of whom 10 were Caucasian and 15 were African American. Data were collected on both serum estradiol as well as body mass index (BMI) = weight (kg)/height2 (m2), which is an important measure of overall obesity. The data are shown in Table 9.16. The distribution of serum estradiol is usually highly skewed (especially for premenopausal women), and we are reluctant to assume normality. HW Question: What test can we use to compare the distribution of serum estradiol for Caucasian vs. African American women? Implement the test and report a two-tailed p-value based on large sample methods Here's my approach and I'm not sure if this is correct. I am using the Wilcoxon rank sum test for this problem. Group 1 (African-American): n=15…
Traumatic Brain Injury (TBI) is a significant health problem. TBI is caused by impacts to the head that might occurduring contact sports, motor vehicle accidents, and similar events. TBI is known to produce cognitive impairments and reductions in brain volume. In a recent, repeated-measures study on TBI, Zagorchev et al.(2016) observed that the size of the amygdala among mild TBI patients was reduced at 12 months after injury, relative to two months after injury. Suppose that a researcher is interested in replicating and extending this observation. She recruits n=8 participants with mild TBI and records the volume of a brain region at 2 months and again and again at 12 months. Her data are listed below a.) Test the hypothesis that volume of the brain region changed between 2 & 12 months. Use α=0.05, two-tailed b.) Compute the 80% confidence interval for the mean change in attention span for the population
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. One hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 50 participants who receive the experimental medication, 30 report a reduction of symptoms as compared to 15 participants of 50 assigned to the placebo. Generate a 95% CI for the difference in proportions of participants reporting a reduction of symptoms between the experimental and placebo groups.
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. One hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 50 participants who receive the experimental medication, 30 report a reduction of symptoms as compared to 15 participants of 50 assigned to the placebo. Generate a 95% CI for the difference in proportions of participants reporting a reduction of symptoms between the experimental and placebo groups. A) (1.237, 3.232) B) (0.114, 0.486) C) (0.600, 0.300) D) (1.529, 8.012) I need help understanding formula to come up with the correct answer.
A clinical trial is conducted to compare an experimental medication to placebo to reduce the symptoms of asthma. One hundred participants are enrolled in the study and randomized to receive either the experimental medication or placebo. The primary outcome is self-reported reduction of symptoms. Among 50 participants who receive the experimental medication, 30 report a reduction of symptoms as compared to 15 participants of 50 assigned to the placebo. Generate a 95% CI for the difference in proportions of participants reporting a reduction of symptoms between the experimental and placebo groups. Please explain answer and will need break down on how it could be done in EXCEL if possible. Please and Thank you
A researcher uncovers that there is a significant interaction between the factor of marital status (i.e., married or non-married) and participant sex (i.e., male or female) regarding well-being among a sample with n = 6 participants in each condition. What would the critical value for the F-ratio be for a hypothesis test examining the difference in well-being between married men and women using an alpha level of α = 0.01? Group of answer choices F = 3.49 F = 5.85 F = 8.10 F = 4.35
According to a certain government agency for a large country, the proportion of fatal traffic accidents in the country in which the driver had a positive blood alcohol concentration (BAC) is 0.33. Suppose a random sample of 109 traffic fatalities in a certain region results in 45 that involved a positive BAC. Does the sample evidence suggest that the region has a higher proportion of traffic fatalities involving a positive BAC than the country at the x = 0.01 level of significance? Because npo (1-P) requirements for testing the hypothesis (Round to one decimal place as needed.) = 10, the sample size is satisfied. 5% of the population size, and the sample the
According to a certain government agency for a large country, the proportion of fatal traffic accidents in the country in which the driver had a positive blood alcohol concentration (BAC) is 0.34. Suppose a random sample of 109 traffic fatalities in a certain region results in 50 that involved a positive BAC. Does the sample evidence suggest that the region has a higher proportion of traffic fatalities involving a positive BAC than the country at the x = 0.01 level of significance? Because npo (1-Po) = 24.5 > 10, the sample size is (Round to one decimal place as needed.) What are the null and alternative hypotheses? p = 0.34 versus H₁: p > 0.34 Ho: p (Type integers or decimals. Do not round.) Find the test statistic, Zo. Zo = 2.62 (Round to two decimal places as needed.) Find the P-value. P-value = (Round to three decimal places as needed.) less than 5% of the population size, and the sample is given to be random, the requirements for testing the hypothesis are satisfied.